Deutsch English Français

Contact

EP2666113

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP2666113

EP2666113 - PHARMACEUTICAL PRODUCT AND COMMUNICATION TOOL [Right-click to bookmark this link]
Status	The application has been refused Status updated on 01.07.2022 Database last updated on 11.04.2026
Former	Examination is in progress Status updated on 31.03.2017
Most recent event Tooltip	01.07.2022	Refusal of application	published on 03.08.2022 [2022/31]
Applicant(s)	For all designated states Intellectual Property Enabler Stockholm AB Tegnebyvägen 35 168 56 Bromma / SE
	[2021/09]
Former [2019/52]	For all designated states ScientificMed Sweden AB Saltmätargatan 9, 3 tr 113 59 Stockholm / SE
Former [2013/48]	For all designated states Scientificmed Sweden AB Lindhagensterrassen 9 112 18 Stockholm / SE
Inventor(s)	01 / CEDERLUND, Johan Tegnebyvägen 35 SE-168 55 Bromma / SE
	02 / FJELLSTRÖM, Jan c/o ScientificMed Sweden AB Lindhagensterrassen 9 S-112 18 Stockholm / SE
	[2013/48]
Representative(s)	Zacco Sweden AB P.O. Box 5581 Löjtnantsgatan 21 114 85 Stockholm / SE
	[N/P]
Former [2013/48]	Brann AB P.O. Box 12246 102 26 Stockholm / SE
Application number, filing date	12702463.6	20.01.2012
	WO2012EP50908
Priority number, date	US201161435079P	21.01.2011 Original published format: US 201161435079 P
	EP20110151683	21.01.2011 Original published format: EP 11151683
	[2013/48]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2012098245
	Date:	26.07.2012
	Language:	EN
	[2012/30]
	Type:	A1 Application with search report
	No.:	EP2666113
	Date:	27.11.2013
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 26.07.2012 takes the place of the publication of the European patent application.
	[2013/48]
Search report(s)	International search report - published on:	EP	26.07.2012
Classification	IPC:	G06F19/00	[2013/48]
	CPC:	G06Q30/0203 (EP,US); G16H10/20 (EP,US); G16H20/10 (EP,US); G16H40/20 (EP,US); G16H50/70 (EP)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/48]
Title	German:	PHARMAZEUTISCHES PRODUKT UND KOMMUNIKATIONSINSTRUMENT	[2013/48]
	English:	PHARMACEUTICAL PRODUCT AND COMMUNICATION TOOL	[2013/48]
	French:	PRODUIT PHARMACEUTIQUE ET OUTIL DE COMMUNICATION	[2013/48]
Entry into regional phase	14.08.2013	National basic fee paid
	14.08.2013	Designation fee(s) paid
	14.08.2013	Examination fee paid
Examination procedure	14.08.2013	Examination requested [2013/48]
	02.04.2014	Amendment by applicant (claims and/or description)
	04.04.2017	Despatch of a communication from the examining division (Time limit: M04)
	11.08.2017	Reply to a communication from the examining division
	17.09.2018	Date of oral proceedings
	08.10.2018	Despatch of communication that the application is refused, reason: substantive examination [2022/31]
	08.10.2018	Minutes of oral proceedings despatched
	04.04.2022	Application refused, date of legal effect [2022/31]
Appeal following examination	17.12.2018	Appeal received No. T0752/19
	18.02.2019	Statement of grounds filed
	04.04.2022	Result of appeal procedure: appeal of the applicant was rejected
	27.06.2022	Despatch of the decision of the Board of Appeal
	04.04.2022	Date of oral proceedings
Divisional application(s)	EP22166472.5
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 04.04.2017
Fees paid	Renewal fee
	23.01.2014	Renewal fee patent year 03
	30.01.2015	Renewal fee patent year 04
	26.01.2016	Renewal fee patent year 05
	30.01.2017	Renewal fee patent year 06
	31.01.2018	Renewal fee patent year 07
	31.01.2019	Renewal fee patent year 08
	15.01.2020	Renewal fee patent year 09
	26.01.2021	Renewal fee patent year 10
	21.12.2021	Renewal fee patent year 11
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[I] US2002035486 (HUYN NAM Q et al.) [I] 1-20 * abstract * * paragraphs [0003] - [0016] * * paragraphs [0037] , [0041] * * figures 14,16 *
		[I] US2009234240 (KUENZLER RICHARD O et al.) [I] 1-20 * paragraphs [0071] - [0077] *
	Examination	LARS WALLENTIN ET AL: "Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes", NEW ENGLAND JOURNAL OF MEDICINE, THE - NEJM -, vol. 361, no. 11, 10 September 2009 (2009-09-10), US, pages 1045 - 1057, XP055436218, ISSN: 0028-4793, DOI: 10.1056/NEJMoa0904327 DOI: http://dx.doi.org/10.1056/NEJMoa0904327
		HELMS, R.A. AND QUAN, D.J.: "Textbook of Therapeutics: Drug and Disease Management", 1 January 2006, LIPPINCOTT WILLIAMS & WILKINS, ISBN: 0781757347, pages: 480
		HOEMAN, S.P.: "Rehabilitation Nursing: Prevention, Intervention, and Outcomes", 1 January 2008, ELSEVIER HEALTH SCIENCES, ISBN: 0323045553, pages: 720
		PARTHASARATHI G. ET AL.: "A Text Book of Clinical Pharmacy Practice: Essential Concepts and Skills", 1 January 2004, ORIENT BLACKSWAN, ISBN: 8125026312, pages: 66 - 67
		HAAS, L.J.: "Handbook of Primary Care Psychology", 19 August 2004, OXFORD UNIVERSITY PRESS, ISBN: 0198034083, pages: 167
		"Textbook of Therapeutics: Drug and Disease Management", 1 June 2006, LIPPINCOTT WILLIAMS AND WILKINS, ISBN: 978-0-7817-5734-8, article BRIAN CROSS: "Chapter 20. Hypertension, Section VI. Cardiovascular disorders", pages: 480, XP055499420
	by applicant	WO02095352
		MCCANN ET AL., EUROPEAN JOURNAL OF CANCER CARE, vol. 18, pages 156 - 164
		WILD D ET AL., VALUE HEALTH, vol. 2, 2005, pages 94 - 104
		SHEEHAN DV; KEENE MS; EADDY M ET AL.: "Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.", CNS DRUGS, 2008, pages 22
		STEIN MB; CANTRELL CR; SOKOL MC ET AL.: "Antidepressant adherence and medical resource use among managed care patients with anxiety disorders.", PSYCHIATR SERV. 2006;57

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.